Use of a Withania extract for the treatment of amyloid-related diseases
US10596216B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2015 |
| Grant date | Mar 24, 2020 |
| Priority date | — |
| Expiry date | Mar 23, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2236/39
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a composition from a plant extract of Withania somnifera, to treat or prevent amyloid-related diseases, including Alzheimer disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.